Pathogens

Pathogens

Vaccines and Therapy

track_changes Track Tracking Be alerted when new articles are added in this gateway (manage your tracking alerts via your account) Stop tracking this gateway
1-20 of 57 ARTICLES
https://doi.org/10.12688/f1000research.167372.1
Review metrics
Recent trends in epidemiology, clinical manifestations, and management of human metapneumovirus infections
[version 1; peer review: 1 approved]
Peer Reviewers Sreeja PA and Aman Suresh T
PUBLISHED 28 Jul 2025
https://doi.org/10.12688/f1000research.144903.3
Review metrics
Revised
Unveiling the Group A Streptococcus Vaccine-Based L-Rhamnose from Backbone of Group A Carbohydrate: Current Insight Against Acute Rheumatic Fever to Reduce the Global Burden of Rheumatic Heart Disease
[version 3; peer review: 2 approved]
Peer Reviewers Arif Nur Muhammad Ansori; Mark Kaddumukasa
LATEST VERSION PUBLISHED 30 Jan 2025
https://doi.org/10.12688/f1000research.134121.6
Opinion Article metrics
Revised
Viral interactions with host factors (TIM-1, TAM -receptors, Glut-1) are related to the disruption of glucose and ascorbate transport and homeostasis, causing the haemorrhagic manifestations of viral haemorrhagic fevers.
[version 6; peer review: 2 approved]
Peer Reviewers Hong-Li Liu; Chao Qin
LATEST VERSION PUBLISHED 09 Dec 2024
https://doi.org/10.12688/f1000research.127138.2
Research Article metrics
Revised
An open label, single arm, pilot study to evaluate the safety, tolerability, and efficacy of daily fluconazole 150 mg in subjects suffering from Tinea cruris and Tinea corporis
[version 2; peer review: 3 approved with reservations, 2 not approved]
Peer Reviewers Kabir Sardana; Clara Gómez and Enrique Alberdi; David W Denning; Paulo Henrique Fonseca Carmo; Saumya Panda
  • Funder
  • FDC Company, India
LATEST VERSION PUBLISHED 06 Dec 2024
https://doi.org/10.12688/f1000research.129080.2
Review metrics
Revised
Hospital-acquired and ventilator-associated pneumonia caused by multidrug-resistant Gram-negative pathogens: Understanding epidemiology, resistance patterns, and implications with COVID-19
[version 2; peer review: 2 approved]
Peer Reviewers Ghassan Dbaibo; Arjana Tambić Andrašević
  • Funder
  • Lebanese International University
LATEST VERSION PUBLISHED 25 Mar 2024
https://doi.org/10.12688/f1000research.74576.4
Brief Report metrics
Revised
Transmission of yellow fever vaccine virus from breast feeding mothers to their infants: reporting of yellow fever virus (YFV) RNA detection in milk specimens
[version 4; peer review: 1 approved, 2 approved with reservations]
Peer Reviewers Leo G Visser; Ralph Huits; Albert Koulman
LATEST VERSION PUBLISHED 29 Feb 2024
https://doi.org/10.12688/f1000research.128116.2
Research Article metrics
Revised
Factors affecting HBV DNA suppression in chronic hepatitis B patients treated with tenofovir disoproxil fumarate
[version 2; peer review: 2 approved]
Peer Reviewers I Ketut Mariadi; Hendra Koncoro
LATEST VERSION PUBLISHED 24 Aug 2023
https://doi.org/10.12688/f1000research.124947.3
Research Article metrics
Revised
Acacia mangium: A promising plant for isolating anti-hepatitis C virus agents
[version 3; peer review: 1 approved, 2 approved with reservations, 1 not approved]
Peer Reviewers Ziwen Wang; Courage Sedem Dzah; Borris Rosnay T Galani; Moustafa Sarhan
  • Funder
  • University grant, Airlangga University
LATEST VERSION PUBLISHED 02 Aug 2023
https://doi.org/10.12688/f1000research.109701.2
Review metrics
Revised
4’-fluorouridine as a potential COVID-19 oral drug?: a review
[version 2; peer review: 1 approved with reservations, 1 not approved]
Peer Reviewers Steven De Jonghe; Slobodan M. Janković
  • Funder
  • Lembaga Pengelola Dana Pendidikan (LPDP), managed by the Indonesian Science Fund (ISF)
LATEST VERSION PUBLISHED 22 May 2023
https://doi.org/10.12688/f1000research.126345.1
Research Article metrics
Risk factors and mortality outcomes of extended-spectrum beta-lactamase producing Escherichia coli bacteremia: A retrospective cohort study from two Indonesian referral hospitals
[version 1; peer review: 2 not approved]
Peer Reviewers Matteo Boattini; Werner Albrich, Tamara Dörr and Reto Thoma
PUBLISHED 07 Dec 2022
https://doi.org/10.12688/f1000research.75869.2
Systematic Review metrics
Revised
Analysis of the safety and immunogenicity profile of an azoximer bromide polymer-adjuvanted subunit influenza vaccine.
[version 2; peer review: 2 approved]
Peer Reviewers Marek Petra; Lyazzat Yeraliyeva
  • Funder
  • NPO Petrovax Pharm LLC
LATEST VERSION PUBLISHED 03 Nov 2022
https://doi.org/10.12688/f1000research.110268.2
Research Article metrics
Revised
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain
[version 2; peer review: 2 approved]
Peer Reviewers Manushak Avagyan; Durga Neupane
  • Funder
  • Sociedad Española de Oncología Médica
LATEST VERSION PUBLISHED 26 Jul 2022
https://doi.org/10.12688/f1000research.109397.1
Research Article metrics
Metabolic changes in chronic hepatitis C patients receiving direct acting antivirals
[version 1; peer review: 2 approved with reservations]
Peer Reviewers Luciana Diniz Silva; Tatsuo Kanda
PUBLISHED 13 Jun 2022
https://doi.org/10.12688/f1000research.26756.2
Research Article metrics
Revised
Characterization of sulfated polysaccharide activity against virulent Plasmodium falciparum PHISTb/RLP1 protein
[version 2; peer review: 2 approved]
Peer Reviewers Eusébio Macete; Abraham Madariaga
  • Funders
  • DELTAS Africa Initiative
  • Armed Forces Health Surveillance Branch
LATEST VERSION PUBLISHED 29 Apr 2022
https://doi.org/10.12688/f1000research.109586.1
Research Article metrics
Interaction of surface glycoprotein of SARS-CoV-2 variants of concern with potential drug candidates: A molecular docking study
[version 1; peer review: 2 approved, 1 not approved]
Peer Reviewers Akinwunmi Oluwaseun Adeoye; Nurdjannah Jane Niode; Thomas Caulfield
  • Funders
  • Research to Stop Neglected Tropical Diseases transmission (R2STOP)
  • Leprosy Research Initiative
  • Indian Council of Medical Research
  • Department of Biotechnology, Ministry of Science and Technology, India
PUBLISHED 07 Apr 2022
https://doi.org/10.12688/f1000research.39214.2
Opinion Article metrics
Revised
A roadmap for the generation of benchmarking resources for antimicrobial resistance detection using next generation sequencing
[version 2; peer review: 1 approved, 2 approved with reservations]
Peer Reviewers Rene Hendriksen; Anna Abramova and Marcus Wenne; Enrico Lavezzo and Emilio Ispano
  • Funders
  • Biotechnology and Biological Sciences Research Counci
  • European Commission
LATEST VERSION PUBLISHED 16 Mar 2022
https://doi.org/10.12688/f1000research.110281.1
Systematic Review metrics
Seroconversion rates among different designs of COVID-19 vaccines: a network meta-analysis of randomized controlled trials
[version 1; peer review: 1 approved with reservations]
Peer Reviewers Jonghoon Kang
PUBLISHED 10 Mar 2022
https://doi.org/10.12688/f1000research.75537.1
Research Article metrics
COVID-19: Comparison of immunogenicity response between natural and post-vaccination infections
[version 1; peer review: 1 approved, 1 not approved]
Peer Reviewers Anggraini Dwi Sensusiati; Marios Politis
  • Funder
  • RSUP Prof.dr.R.D Kandou
PUBLISHED 22 Feb 2022
https://doi.org/10.12688/f1000research.26452.1
Software Tool Article metrics
Lessons learned in virulence factor identification and data management from a hackathon on microbial virulence
[version 1; peer review: 1 approved, 1 approved with reservations]
Peer Reviewers Rick Stevens and James Davis; Kevin Tyler
  • Funders
  • Fundação para a Ciência e a Tecnologia
  • Scientific and Technological Research Council of Turkey
  • Intramural Research Program of the National Library of Medicine
PUBLISHED 09 Feb 2022
https://doi.org/10.12688/f1000research.28327.2
Review metrics
Revised
Novel antifungal agents in clinical trials
[version 2; peer review: 2 approved]
Peer Reviewers Charalampos Antachopoulos; Shahram Mahmoudi
  • Funder
  • Henry Schueller Foundation
LATEST VERSION PUBLISHED 12 Jan 2022
1-20 of 57 ARTICLES
Gateway Areas
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.